DMED — Diagnamed Holdings Income Statement
0.000.00%
Last trade - 00:00
- CA$1.61m
- CA$1.23m
2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Total Revenue | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 1.95 | 1.13 | 1.28 |
Operating Profit | -1.95 | -1.13 | -1.28 |
Net Income Before Taxes | -1.95 | -1.13 | -1.28 |
Net Income After Taxes | -1.95 | -1.13 | -1.28 |
Net Income Before Extraordinary Items | |||
Net Income | -1.95 | -1.13 | -1.28 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -1.95 | -1.13 | -1.28 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.026 | -0.015 | -0.016 |